TELA Logo

TELA Bio, Inc. (TELA) 

NASDAQ
Market Cap
$127.96M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
266 of 809
Rank in Industry
38 of 107

Largest Insider Buys in Sector

TELA Stock Price History Chart

TELA Stock Performance

About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Insider Activity of TELA Bio, Inc.

Over the last 12 months, insiders at TELA Bio, Inc. have bought $109,603 and sold $0 worth of TELA Bio, Inc. stock.

On average, over the past 5 years, insiders at TELA Bio, Inc. have bought $11.11M and sold $1.3M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Cuca Roberto (COO and CFO) — $134,814. KOBLISH ANTONY (Chief Executive Officer) — $49,976. Firestone Gregory A. (Chief Business Officer) — $14,688.

The last purchase of 2,600 shares for transaction amount of $14,688 was made by Firestone Gregory A. (Chief Business Officer) on 2023‑12‑05.

List of Insider Buy and Sell Transactions, TELA Bio, Inc.

2023-12-05PurchaseFirestone Gregory A.Chief Business Officer
2,600
0.011%
$5.65$14,688+6.23%
2023-11-14PurchaseKOBLISH ANTONYChief Executive Officer
11,000
0.0454%
$4.54$49,976+23.90%
2023-11-14PurchaseCuca RobertoCOO and CFO
10,000
0.0408%
$4.49$44,938+23.90%
2023-04-21SaleORBIMED ADVISORS LLC10 percent owner
27,700
0.1432%
$9.41$260,657-24.97%
2023-04-20SaleORBIMED ADVISORS LLC10 percent owner
28,300
0.1502%
$9.43$266,869-22.89%
2023-04-19SaleORBIMED ADVISORS LLC10 percent owner
136,000
0.7142%
$9.30$1.26M-22.43%
2022-11-03PurchaseOpaleye Management Inc.director
20,262
0.1236%
$7.81$158,285+26.43%
2022-10-11PurchaseOpaleye Management Inc.director
16,000
0.0971%
$8.00$128,000+22.84%
2022-08-17PurchaseEW Healthcare Partners Fund 2-UGP, LLC
500,000
2.8654%
$8.00$4M+19.45%
2022-08-16PurchaseOpaleye Management Inc.
15,000
0.0881%
$8.00$120,000+22.39%
2022-08-10PurchaseOpaleye Management Inc.
11,500
0.0684%
$8.52$98,006+16.37%
2022-08-01PurchaseOpaleye Management Inc.10 percent owner
4,979
0.0296%
$7.96$39,632+24.38%
2022-07-22PurchaseOpaleye Management Inc.
5,000
0.0299%
$8.02$40,105+24.06%
2022-07-21PurchaseOpaleye Management Inc.
9,500
0.0564%
$8.03$76,282+22.68%
2022-07-20PurchaseOpaleye Management Inc.
4,500
0.0268%
$8.08$36,346+22.15%
2022-07-14PurchaseEW HEALTHCARE PARTNERS FUND 2, L.P.See Remarks
5,000
0.0299%
$8.01$40,050
2022-07-11PurchaseEW Healthcare Partners Fund 2-UGP, LLC
5,000
0.0302%
$8.03$40,150+21.28%
2022-07-06PurchaseEW Healthcare Partners Fund 2-UGP, LLC
5,000
0.0314%
$8.07$40,350+24.87%
2022-06-30PurchaseEW Healthcare Partners Fund 2-UGP, LLC
5,000
0.032%
$7.52$37,600+35.52%
2022-06-27PurchaseEW Healthcare Partners Fund 2-UGP, LLC
5,000
0.0342%
$7.22$36,100+30.76%

Insider Historical Profitability

<0.0001%
KOBLISH ANTONYChief Executive Officer
303634
1.2399%
$5.1910
Cuca RobertoCOO and CFO
62371
0.2547%
$5.1960<0.0001%
Firestone Gregory A.Chief Business Officer
35511
0.145%
$5.1910
EW Healthcare Partners Fund 2-UGP, LLC
4105709
16.7657%
$5.19250+12.99%
EW HEALTHCARE PARTNERS FUND 2, L.P.
3610709
13.4735%
$5.191170<0.0001%
ORBIMED ADVISORS LLC10 percent owner
2835542
11.5789%
$5.1913+2.92%
Opaleye Management Inc.director
1948000
7.9547%
$5.19100+27.85%
RTW INVESTMENTS, LP10 percent owner
1139358
4.6526%
$5.1911+23.06%
Oliva Adele C
888664
3.6289%
$5.1910+2.92%
Quaker BioVentures II LP10 percent owner
888664
3.6289%
$5.1910+2.92%
Zuga Mattdirector
260808
1.065%
$5.1910+2.92%
Azarbarzin Kurtdirector
260808
1.065%
$5.1910+2.92%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Essex Woodlands Management Inc$23.31M16.674.11M0%+$06.78
OrbiMed$16.08M11.52.84M0%+$00.33
First Light Asset Management$15.62M11.172.75M+7.8%+$1.13M1.23
Aigh Capital Management Llc$8.02M5.741.42M+2.71%+$211,547.704.76
Nantahala Capital Management Llc$6.22M4.451.1M0%+$00.64
BlackRock$5.92M4.231.04M-3.23%-$197,474.77<0.0001
The Vanguard Group$5.7M4.081.01M+0.72%+$40,818.33<0.0001
Silverarc Capital Management Llc$4.4M3.15776,851-2.29%-$103,358.431.3
Velan Capital$4.23M3.03746,087+862.69%+$3.79M2.3
Federated Hermes$4.04M2.89712,3000%+$00.01
Stonepine Capital Management Llc$3.9M2.79688,200+116.56%+$2.1M3.15
Paradigm Capital Management Inc Ny$2.92M2.09515,265+3.36%+$95,057.570.14
Kennedy Capital Management Inc$2.17M1.55383,075+0.23%+$4,881.870.05
State Street$2.13M1.52375,368+17.1%+$310,857.81<0.0001
Geode Capital Management$1.98M1.42349,723+0.88%+$17,357.89<0.0001
Hudson Bay Capital Management LP$1.75M1.25308,642-68.82%-$3.86M0.05
Perkins Capital Management Inc$1.19M0.85210,000-0.12%-$1,417.861.03
Meros Investment Management Lp$852,422.000.61150,339+88.07%+$399,167.940.38
Northern Trust$754,042.000.54132,988-1.56%-$11,929.68<0.0001
Nuveen$582,774.000.42102,782+233.03%+$407,780.77<0.0001
Parkman Healthcare Partners Llc$553,778.000.497,668-5.52%-$32,358.720.07
Russell Investments Group Ltd$538,309.000.3994,940+107.58%+$278,986.27<0.01
PNC Financial Services$304,700.000.2253,739+0.24%+$720.09<0.0001
Morgan Stanley$297,069.000.2152,393-41.93%-$214,485.26<0.0001
Charles Schwab$243,305.000.1742,911-6.53%-$17,009.97<0.0001
BNY Mellon$240,323.000.1742,385-12.63%-$34,740.10<0.0001
Bridgeway Capital Management$209,790.000.1537,000-53.16%-$238,140.00<0.01
Atom Investors Lp$201,926.000.1435,613+41.35%+$59,075.820.03
Schonfeld Group$198,450.000.1435,000-35.9%-$111,132.00<0.01
Calamos Advisors LLC$191,510.000.1433,776-6.1%-$12,439.99<0.01
Xtx Topco Ltd$189,741.000.1433,464New+$189,741.000.01
Bank of America$161,220.000.1228,434-6.87%-$11,889.93<0.0001
Gsa Capital Partners Llp$138,000.000.124,385New+$138,000.000.01
UBS$102,128.000.0718,012-97.39%-$3.8M<0.0001
Deutsche Bank$92,880.000.0716,3810%+$0<0.0001
RhumbLine Advisers$85,580.000.0615,095+2.23%+$1,865.24<0.0001
Citadel Advisors LLC$73,699.000.0512,998New+$73,699.00<0.0001
Goldman Sachs$71,493.000.0512,609New+$71,493.00<0.0001
Barclays$65,000.000.0511,437-48.64%-$61,567.28<0.0001
New York State Common Retirement Fund$54,000.000.049,610+1.77%+$938.40<0.0001
American International Group$45,218.000.037,975-0.84%-$385.56<0.0001
JPMorgan Chase$37,892.000.036,683-39.14%-$24,369.27<0.0001
Fidelity Investments$37,904.000.036,685+0.2%+$73.71<0.0001
Royal Bank of Canada$31,000.000.025,540+9.64%+$2,725.09<0.0001
Wells Fargo$27,420.000.024,836+15.47%+$3,674.14<0.0001
Worth Venture Partners$21,886.000.023,860-98.88%-$1.94M0.16
Citigroup$15,133.000.012,669+13.09%+$1,752.00<0.0001
Legal & General$10,983.000.011,9370%+$0<0.0001
Tower Research Capital$9,843.000.011,736-2.42%-$243.81<0.0001
Ameritas Investment Partners Inc$7,433.000.011,3110%+$0<0.0001